Pathstone Family Office’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$648K Buy
7,640
+606
+9% +$54.7K ﹤0.01% 915
2023
Q2
$700K Sell
7,034
-528
-7% -$49.7K 0.01% 610
2023
Q1
$729K Sell
7,562
-7,822
-51% -$724K 0.01% 544
2022
Q4
$1.41M Sell
15,384
-1,420
-8% -$121K 0.01% 628
2022
Q3
$1.34M Buy
+16,804
New +$1.42M 0.01% 603
2019
Q2
Sell
-83
Closed -$4K 698
2019
Q1
$4K Hold
83
﹤0.01% 626
2018
Q4
$5K Buy
+83
New +$5.2K ﹤0.01% 373
2017
Q2
Sell
-6
Closed 450
2017
Q1
$0 Buy
+6
New +$361 ﹤0.01% 586

Other funds holding DOX

Pathstone Family Office's DOX Position: Q3 2023 in Review

Pathstone Family Office increased its Amdocs (DOX) stake by 8.6% in Q3 2023, buying an estimated $54.7K and bringing the position to 7,640 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #915.

Pathstone Family Office first reported a position in DOX in Q1 2017 and has held it in 8 quarters since. The position peaked at $1.41M in Q4 2022. 482 funds tracked by Wall St. Rank hold DOX as of Q3 2023.

  • Pathstone Family Office held 7,640 shares of Amdocs worth $648K as of Q3 2023.
  • Pathstone Family Office bought 606 Amdocs shares in Q3 2023, an estimated $54.7K.
  • Amdocs made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #915 holding.
  • Pathstone Family Office first reported a position in Amdocs in Q1 2017 and has held it in 8 quarters since.
  • Pathstone Family Office's Amdocs position peaked at $1.41M in Q4 2022.
  • 482 funds tracked by Wall St. Rank held Amdocs as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.